Curcumin Analog GO-Y030 Triggers JNK and P38 Signalling to Activate Apoptotic Cascades in Human Osteosarcoma Cells

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2025 Feb 13

PMID 39945243

Authors

Yu-Hsien Lin

Jia-Sin Yang

Chia-Hsuan Chou

Tzu-Yu Huang

Shun-Fa Yang

Ko-Hsiu Lu

Affiliations

Soon will be listed here.

Abstract

Osteosarcoma, the most common primary bone cancer in adolescents, often carries a grim prognosis due to its high metastatic potential. Due to its low bioavailability, curcumin limits its adjuvant efficacy in improving prognosis and long-term survival in osteosarcoma patients. To investigate apoptosis induced by the synthesised curcumin analog GO-Y030 in human osteosarcoma cells, flow cytometry, annexin V-fluorescein isothiocyanate-labelled/propidium iodide staining, human apoptosis array, and Western blotting were used. GO-Y030 dose-dependently reduced viability and induced sub-G1 arrest and apoptosis in human osteosarcoma U2OS and 143B cells. GO-Y030 significantly activated caspases 8, 9, and 3, while suppressing cellular inhibitors of apoptosis protein 1 (cIAP-1) and X-chromosome-linked IAP. GO-Y030 increased the phosphorylation of extracellular signal-regulated protein kinases (ERK)1/2, c-Jun N-terminal kinases (JNK)1/2, and p38. Inhibitors of JNK (JNK-IN-8) and p38 (SB203580) suppressed GO-Y030-induced cleavage of caspases 8, 9, and 3, whereas co-treatment with the ERK inhibitor (U0126) did not lessen their activation. Overall, GO-Y030 triggers both extrinsic and intrinsic apoptotic cascades in U2OS and 143B cells by activating the JNK1/2 and p38 pathways, shedding light on its mechanism of action against human osteosarcoma cells.

References

Maruyama T, Kobayashi S, Nakatsukasa H, Moritoki Y, Taguchi D, Sunagawa Y . The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells. Front Immunol. 2021; 12:687669. PMC: 8261301. DOI: 10.3389/fimmu.2021.687669. View

Golmohammadi M, Zamanian M, Al-Ani A, Jabbar T, Kareem A, Aghaei Z . Targeting STAT3 signaling pathway by curcumin and its analogues for breast cancer: A narrative review. Animal Model Exp Med. 2024; 7(6):853-867. PMC: 11680487. DOI: 10.1002/ame2.12491. View

Lu K, Lu P, Lin C, Yang S . Curcumin in human osteosarcoma: From analogs to carriers. Drug Discov Today. 2022; 28(2):103437. DOI: 10.1016/j.drudis.2022.103437. View

Lu K, Yang H, Su C, Lue K, Yang S, Hsieh Y . Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways. Food Chem Toxicol. 2012; 52:193-9. DOI: 10.1016/j.fct.2012.11.019. View

Arndt C, Crist W . Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999; 341(5):342-52. DOI: 10.1056/NEJM199907293410507. View

Su C, Kao S, Chen Y, Hsieh Y, Yang W, Tsai M . Curcumin Analog L48H37 Induces Apoptosis in Human Oral Cancer Cells by Activating Caspase Cascades and Downregulating the Inhibitor of Apoptosis Proteins through JNK/p38 Signaling. Am J Chin Med. 2024; 52(2):565-581. DOI: 10.1142/S0192415X24500241. View

Sharma R, Ireson C, Verschoyle R, Hill K, Williams M, Leuratti C . Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin Cancer Res. 2001; 7(5):1452-8. View

Menon L, Kuttan R, Kuttan G . Anti-metastatic activity of curcumin and catechin. Cancer Lett. 1999; 141(1-2):159-65. DOI: 10.1016/s0304-3835(99)00098-1. View

Shimizu K, Funamoto M, Genpei M, Sunagawa Y, Katanasaka Y, Miyazaki Y . Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo. Eur Cardiol. 2018; 12(2):106. PMC: 6213181. DOI: 10.15420/ecr.2017:23:15. View

10.

Lu K, Chen P, Lue K, Lai M, Lin M, Hsieh Y . 2'-hydroxyflavanone induces apoptosis of human osteosarcoma 143 B cells by activating the extrinsic TRAIL- and intrinsic mitochondria-mediated pathways. Nutr Cancer. 2014; 66(4):625-35. DOI: 10.1080/01635581.2014.894100. View

11.

Oertel S, Blattmann C, Rieken S, Jensen A, Combs S, Huber P . Radiotherapy in the treatment of primary osteosarcoma--a single center experience. Tumori. 2010; 96(4):582-8. DOI: 10.1177/030089161009600411. View

12.

Ohori H, Yamakoshi H, Tomizawa M, Shibuya M, Kakudo Y, Takahashi A . Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther. 2006; 5(10):2563-71. DOI: 10.1158/1535-7163.MCT-06-0174. View

13.

Uehara Y, Inoue M, Fukuda K, Yamakoshi H, Hosoi Y, Kanda H . Inhibition of β-catenin and STAT3 with a curcumin analog suppresses gastric carcinogenesis in vivo. Gastric Cancer. 2014; 18(4):774-83. PMC: 4572076. DOI: 10.1007/s10120-014-0434-3. View

14.

Lu K, Lu E, Lin C, Yang J, Yang S . New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma. Pharmacol Ther. 2020; 214:107611. DOI: 10.1016/j.pharmthera.2020.107611. View

15.

Yang X, Paul Thomas D, Zhang X, Culver B, Alexander B, Murdoch W . Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2005; 26(1):85-90. DOI: 10.1161/01.ATV.0000191635.00744.b6. View

16.

Lu K, Lu P, Lu E, Lin C, Yang S . Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma. Int J Biol Sci. 2023; 19(4):1241-1265. PMC: 10008701. DOI: 10.7150/ijbs.80590. View

17.

Yang J, Chou C, Hsieh Y, Lu P, Lin Y, Yang S . Morin inhibits osteosarcoma migration and invasion by suppressing urokinase plasminogen activator through a signal transducer and an activator of transcription 3. Environ Toxicol. 2023; 39(4):2024-2031. DOI: 10.1002/tox.24100. View

18.

Lu K, Chen P, Hsieh Y, Lin C, Cheng F, Chiu P . 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo. Food Chem Toxicol. 2016; 97:177-186. DOI: 10.1016/j.fct.2016.09.006. View

19.

Lu P, Chou C, Yang J, Hsieh Y, Tsai M, Lu K . HO-3867 Induces Apoptosis via the JNK Signaling Pathway in Human Osteosarcoma Cells. Pharmaceutics. 2022; 14(6). PMC: 9229449. DOI: 10.3390/pharmaceutics14061257. View

20.

Kudo C, Yamakoshi H, Sato A, Ohori H, Ishioka C, Iwabuchi Y . Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma. Anticancer Res. 2011; 31(11):3719-26. View